FAM83B has been reported as an important intermediary in EGFR/RAS signaling, and is highly expressed at the mRNA level in several cancers, including breast, cervix, bladder, lung, testis thyroid, and ovary cancer (18). The gene discussed is EGFR; the disease is cancer.